157 related articles for article (PubMed ID: 15483462)
1. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus.
Sundaram R; Lynch MP; Rawale S; Dakappagari N; Young D; Walker CM; Lemonnier F; Jacobson S; Kaumaya PT
J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1329-39. PubMed ID: 15483462
[TBL] [Abstract][Full Text] [Related]
2. A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design.
Sundaram R; Sun Y; Walker CM; Lemonnier FA; Jacobson S; Kaumaya PT
Vaccine; 2003 Jun; 21(21-22):2767-81. PubMed ID: 12798617
[TBL] [Abstract][Full Text] [Related]
3. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin.
Lomas M; Hanon E; Tanaka Y; Bangham CRM; Gould KG
J Gen Virol; 2002 Mar; 83(Pt 3):641-650. PubMed ID: 11842259
[TBL] [Abstract][Full Text] [Related]
4. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
6. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
7. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
[TBL] [Abstract][Full Text] [Related]
9. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
10. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
[TBL] [Abstract][Full Text] [Related]
11. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
Kozako T; Arima N; Toji S; Masamoto I; Akimoto M; Hamada H; Che XF; Fujiwara H; Matsushita K; Tokunaga M; Haraguchi K; Uozumi K; Suzuki S; Takezaki T; Sonoda S
J Immunol; 2006 Oct; 177(8):5718-26. PubMed ID: 17015761
[TBL] [Abstract][Full Text] [Related]
12. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
[TBL] [Abstract][Full Text] [Related]
13. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
[TBL] [Abstract][Full Text] [Related]
14. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.
Höllsberg P; Weber WE; Dangond F; Batra V; Sette A; Hafler DA
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4036-40. PubMed ID: 7732026
[TBL] [Abstract][Full Text] [Related]
16. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant.
Kozako T; Hirata S; Shimizu Y; Satoh Y; Yoshimitsu M; White Y; Lemonnier F; Shimeno H; Soeda S; Arima N
FEBS J; 2011 Apr; 278(8):1358-66. PubMed ID: 21332943
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
[TBL] [Abstract][Full Text] [Related]
18. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S
Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472
[TBL] [Abstract][Full Text] [Related]
19. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
20. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).
Kazanji M; Heraud JM; Merien F; Pique C; de Thé G; Gessain A; Jacobson S
J Gen Virol; 2006 May; 87(Pt 5):1331-1337. PubMed ID: 16603536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
